The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group
Abstract
OBJECTIVE: To provide recommendations [corrected] for the management of acute otitis media (AOM) and the surveillance of drug-resistant Streptococcus pneumoniae (DRSP). Five questions were addressed: (1) Can amoxicillin remain the best initial antimicrobial agent for treating AOM in the current period of increasing prevalence of DRSP? (2) What are suitable alternative agents for use if amoxicillin fails? (3) Should empiric treatment of AOM vary by geographic region? (4) Where can clinicians learn about resistance patterns in their patient populations? (5) What modifications to laboratory surveillance would improve the utility of the information for clinicians treating AOM? PARTICIPANTS: Experts in the management of otitis media and the DRSP Therapeutic Working Group. This group was convened by the CDC to respond to changes in antimicrobial susceptibility among pneumococci and includes clinicians, academicians and public health practitioners. EVIDENCE: Published and unpublished data summarized from the scientific literature and experience from the experts present. PROCESS: [corrected] After group presentations and review of background materials, subgroup chairs prepared draft responses to the five questions, discussed the responses as a group and edited those responses [corrected]. CONCLUSIONS: Oral amoxicillin should remain the first line antimicrobial agent for treating AOM. In view of the increasing prevalence of DRSP, the safety of amoxicillin at higher than standard dosages and evidence that higher dosages of amoxicillin can achieve effective middle ear fluid concentrations, an increase in the dosage used for empiric treatment from 40 to 45 mg/kg/day to 80 to 90 mg/kg/day is recommended. For patients with clinically defined treatment failure after 3 days of therapy, useful alternative agents include oral amoxicillin-clavulanate, cefuroxime axetil and intramuscular ceftriaxone. Many of the 13 other Food and Drug Administration-approved otitis media drugs lack good evidence for efficacy against DRSP. Currently local surveillance data for pneumococcal resistance that are relevant for the clinical management of AOM are not available from most areas in the United States. Recommendations to improve surveillance include establishing criteria for setting susceptibility breakpoints for clinically appropriate antimicrobials to ensure relevance for treating AOM, testing middle ear fluid or nasal swab isolates in addition to sterile site isolates and testing of drugs that are useful in treating AOM. The management of otitis media has entered a new era with the development of DRSP. These recommendations are intended to provide a framework for appropriate clinical and public health responses to this problem.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Management of Infections Caused by Antibiotic-Resistant Streptococcus Pneumoniae
Wood, A. J. J., Friedland, I. R., & McCracken, G. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408113310607 · Cited by 578
The Prevalence of Drug-Resistant Streptococcus pneumoniae In Atlanta
Hofmann, J., Cetron, M. S., Farley, M. M., Baughman, W. S., Facklam, R. R., Elliott, J. A., Deaver, K. A., & Breiman, R. F. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508243330803 · Cited by 503
Doern, G. V., Brueggemann, A., Holley, H. P., & Rauch, A. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1208 · Cited by 482
Pharmacokinetics and pharmacodynamics of antibiotics in otitis media
CRAIG, W. A., & ANDES, D. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199603000-00015 · Cited by 435
The Spread of Multiply Resistant Streptococcus pneumoniae at a Day Care Center in Ohio
Reichler, M. R., Allphin, A. A., Breiman, R. F., Schreiber, J. R., Arnold, J. E., McDougal, L. K., Facklam, R. R., Boxerbaum, B., May, D., Walton, R. O., et al. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.6.1346 · Cited by 376
Self-citationPallares, R., Gudiol, F., Liñares, J., Ariza, J., Rufi, G., Murgui, L., Dorca, J., & Viladrich, P. F. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707023170104 · Cited by 373
Butler, J. C., Hofman, J., Cetron, M. S., Elliott, J. A., Facklam, R. R., Breiman, R. F., & Pneumococcal Sentinel Surveillance Working Group (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.5.986 · Cited by 341
Self-citationOtitis Media—Principles of Judicious Use of Antimicrobial Agents
Dowell, S. F., Marcy, S. M., Phillips, W. R., Gerber, M. A., & Schwartz, B. (1998) · Pediatrics · doi:10.1542/peds.101.s1.165 · Cited by 293
Self-citationHerbert, W. J. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90816-0 · Cited by 260
BLOCK, S. L., HARRISON, C. J., HEDRICK, J. A., TYLER, R. D., SMITH, R. A., KEEGAN, E., & CHARTRAND, S. A. (1995) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199509000-00005 · Cited by 257
Cited by
Diagnosis and Management of Acute Otitis Media
Media, S. O. M. O. A. O. (2004) · Pediatrics · doi:10.1542/peds.113.5.1451 · Cited by 902
Increasing Prevalence of Multidrug-Resistant Streptococcus pneumoniae in the United States
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Lexau, C., Reingold, A., Lefkowitz, L., Cieslak, P. R., Cetron, M., Zell, E. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432603 · Cited by 888
Craig, W. A. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00065-5 · Cited by 556
Antimicrobial Treatment Guidelines for Acute Bacterial Rhinosinusitis
Partnership, S. A. A. H. (2004) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2003.12.003 · Cited by 535
American Academy of Family Physicians, American Academy of Otolaryngology-Head and Neck Surgery, & American Academy of Pediatrics Subcommittee on Otitis Media With Effusion (2004) · Pediatrics · doi:10.1542/peds.113.5.1412 · Cited by 475
Metadata
- Authors
- DOWELL, S. F., BUTLER, J. C., GIEBINK, G. S., JACOBS, M. R., JERNIGAN, D., MUSHER, D. M., RAKOWSKY, A., & SCHWARTZ, B.
- Venue
- The Pediatric Infectious Disease Journal
- Published
- 1999-01
- Volume
- 18
- Issue
- 1
- Pages
- 1-9
- ISSN
- 0891-3668 (ISSN-L)
- OpenAlex
- W2059966590
- Cited by
- 505
- References
- 36
- FWCI
- 75.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. https://app.cochat.ai/papers/10.1097/00006454-199901000-00002
- The paper
- DOWELL, S. F., BUTLER, J. C., GIEBINK, G. S., JACOBS, M. R., JERNIGAN, D., MUSHER, D. M., RAKOWSKY, A., & SCHWARTZ, B. (1999). Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. The Pediatric Infectious Disease Journal. https://doi.org/10.1097/00006454-199901000-00002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.